255 related articles for article (PubMed ID: 21697341)
21. Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen.
Sauerbrei A; Wutzler P
Clin Lab; 2009; 55(1-2):1-7. PubMed ID: 19350844
[TBL] [Abstract][Full Text] [Related]
22. Antibodies to varicella zoster virus in the cerebrospinal fluid of neonates with seizures.
Mustonen K; Mustakangas P; Smeds M; Mannonen L; Uotila L; Vaheri A; Koskiniemi M
Arch Dis Child Fetal Neonatal Ed; 1998 Jan; 78(1):F57-61. PubMed ID: 9536843
[TBL] [Abstract][Full Text] [Related]
23. Class-specific antibody responses to early and late antigens of varicella and herpes simplex viruses.
Schmidt NJ; Gallo D
J Med Virol; 1984; 13(1):1-12. PubMed ID: 6319583
[TBL] [Abstract][Full Text] [Related]
24. Antibodies against varicella-zoster virus and herpes simplex virus deoxythymidine kinase in heterologous infections.
Källander CF; Torfason EG; Olding-Stenkvist E; Sundqvist VA; Diderholm H; Gronowitz JS
J Med Virol; 1989 May; 28(1):30-7. PubMed ID: 2542443
[TBL] [Abstract][Full Text] [Related]
25. Laboratory diagnosis of central nervous system infections caused by herpesviruses.
Sauerbrei A; Wutzler P
J Clin Virol; 2002 Jul; 25 Suppl 1():S45-51. PubMed ID: 12091081
[TBL] [Abstract][Full Text] [Related]
26. Antibody-capture enzyme-linked immunosorbent assays that use enzyme-labelled antigen for detection of virus-specific immunoglobulin M, A and G in patients with varicella or herpes zoster.
van Loon AM; van der Logt JT; Heessen FW; Heeren MC; Zoll J
Epidemiol Infect; 1992 Feb; 108(1):165-74. PubMed ID: 1312479
[TBL] [Abstract][Full Text] [Related]
27. HSV IgG antibody inhibits virus detection in CSF.
Fening SW; Esper F; Scholl D; Huang YT
J Clin Virol; 2012 Oct; 55(2):164-7. PubMed ID: 22841844
[TBL] [Abstract][Full Text] [Related]
28. The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1.
Lowry PW; Koropchak CM; Choi CY; Mocarski ES; Kern ER; Kinchington PR; Arvin AM
Antiviral Res; 1997 Feb; 33(3):187-200. PubMed ID: 9037375
[TBL] [Abstract][Full Text] [Related]
29. Production of specific antibodies by cerebrospinal fluid lymphocytes in patients with herpes zoster, mumps meningitis and herpes simplex virus encephalitis.
Forsberg P; Kam-Hansen S; Frydén A
Scand J Immunol; 1986 Sep; 24(3):261-71. PubMed ID: 3018917
[TBL] [Abstract][Full Text] [Related]
30. Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system.
Gregoire SM; van Pesch V; Goffette S; Peeters A; Sindic CJ
J Neurol Neurosurg Psychiatry; 2006 Aug; 77(8):938-42. PubMed ID: 16844949
[TBL] [Abstract][Full Text] [Related]
31. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.
Sauerbrei A; Wutzler P
J Clin Microbiol; 2006 Sep; 44(9):3094-7. PubMed ID: 16954232
[TBL] [Abstract][Full Text] [Related]
32. Herpes simplex encephalitis. Early diagnosis and immune activation in the acute stage and during long-term follow-up.
Aurelius E
Scand J Infect Dis Suppl; 1993; 89():3-62. PubMed ID: 8235453
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic significance of enzyme linked immuno-sorbent assay for herpes simplex, varicella zoster and cytomegalovirus retinitis.
Madhavan HN; Priya K
Indian J Ophthalmol; 2003 Mar; 51(1):71-5. PubMed ID: 12701866
[TBL] [Abstract][Full Text] [Related]
34. Chemokines and matrix metalloproteinases in cerebrospinal fluid of patients with central nervous system complications caused by varicella-zoster virus.
Lind L; Eriksson K; Grahn A
J Neuroinflammation; 2019 Feb; 16(1):42. PubMed ID: 30777092
[TBL] [Abstract][Full Text] [Related]
35. Incidence and clinical features of herpes simplex viruses (1 and 2) and varicella-zoster virus infections in an adult Korean population with aseptic meningitis or encephalitis.
Choi R; Kim GM; Jo IJ; Sim MS; Song KJ; Kim BJ; Na DL; Huh HJ; Kim JW; Ki CS; Lee NY
J Med Virol; 2014 Jun; 86(6):957-62. PubMed ID: 24610349
[TBL] [Abstract][Full Text] [Related]
36. Incidence of varicella zoster virus infections of the central nervous system in the elderly: a large tertiary hospital-based series (2007-2014).
Arruti M; Piñeiro LD; Salicio Y; Cilla G; Goenaga MA; López de Munain A
J Neurovirol; 2017 Jun; 23(3):451-459. PubMed ID: 28224485
[TBL] [Abstract][Full Text] [Related]
37. [Value of the polymerase chain reaction in the diagnosis of herpes infections of the nervous system].
García-Bardeci D; Pena MJ; Suárez-Bordón P; Aladro Y; Pérez-González C; Lafarga B
Enferm Infecc Microbiol Clin; 2004 Mar; 22(3):150-5. PubMed ID: 14987535
[TBL] [Abstract][Full Text] [Related]
38. A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid.
Kneitz RH; Schubert J; Tollmann F; Zens W; Hedman K; Weissbrich B
BMC Infect Dis; 2004 Sep; 4():33. PubMed ID: 15355548
[TBL] [Abstract][Full Text] [Related]
39. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.
Conde-Glez C; Lazcano-Ponce E; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
Vaccine; 2013 Oct; 31(44):5067-74. PubMed ID: 24021305
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test.
Sauerbrei A; Schäfler A; Hofmann J; Schacke M; Gruhn B; Wutzler P
Clin Vaccine Immunol; 2012 Aug; 19(8):1261-8. PubMed ID: 22718131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]